Sleven, the comment about the future was concerning the Bioverativ case. Didn't the full accurate story there when Denner came aboard but we did know the MDCO story. The top 50 selling drugs are all owned by BP. V will never become what people imagine with a BP in control. If you are sure that after RS this gets bashed down (as happens most times after a RS split but some here swear it won't here because it is already trading below cash) why not liquidate now and pick up much cheaper shares when that happens?
And, the reason I keep mentioning the _______ (what seems to offend or irritate people) is that many here seem to think Amarin should be doing so much better. They obviously don't understand the position that event put the company. Rock vs Hard Place. There is very little they can do. They can't change the dynamic of U.S. sales being stolen for the near future at a minimum and can't either get sales moving in the EU or the two biggies to approve reimbursement.
Market Data 
Markets 
AI
